Latest TAK reports update at 2022-06-29: 2022-Q1 ∙ 2021-Q1
  1. Home
  2. Stock quotes
  3. Takeda Pharmaceutical Company Limited
  4. Financial Ratios
Takeda Pharmaceutical Company Limited logo
Takeda Pharmaceutical Company Limited TAK
$ 13.37 2.45%
mail-toReport an Error

Takeda Pharmaceutical Company Limited Financial Ratios 2011-2024 | TAK

Annual Financial Ratios Takeda Pharmaceutical Company Limited

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 0.1 138.7 35.2 19.3 36.8 51.2 -30.3 36.1 35.8 30.2 16.9

P/S

 0.0 1.9 1.8 2.0 2.4 2.3 2.5 2.3 3.0 2.5 2.9

EPS

 240.7 28.4 140.6 239.3 147.2 - - - - - -

EV (Enterprise Value)

 6.79 T 7.51 T 8.04 T 1.83 T 2.13 T 1.85 T 2.13 T 2.06 T 1.78 T 1.54 T 688 B

EBITDA per Share

 326 230 186 233 200 163 30 179 205 263 300

EV/EBITDA

 13.3 6.3 14.2 2.0 2.8 1.4 2.5 0.8 0.9 0.3 -0.4

PEG

 0.0 -1.85 -0.67 0.31 0.84 -0.33 0.13 -1.93 6.29 -0.6 -1.01

P/B

 0.0 1.3 0.7 1.8 2.2 2.1 2.1 1.6 2.2 1.9 2.0

P/CF

 0.0 - 0.2 0.1 0.3 -0.6 0.5 0.5 0.2 0.1 0.2

ROE %

 7.27 0.94 2.12 9.36 6.07 4.11 -6.82 4.32 6.08 6.17 11.85

ROA %

 2.91 0.35 0.79 4.55 2.64 2.10 -3.39 2.33 3.32 3.47 8.90

ROCE %

 4.57 2.50 1.36 7.18 5.21 4.41 -3.94 3.70 3.67 9.38 15.62

Current Ratio

 1.7 1.1 1.2 1.5 0.9 1.6 1.5 2.0 2.4 1.7 3.6

DSO

 - 79.3 130.4 88.4 93.7 87.0 95.8 95.5 - - -

DIO

 - 254.4 546.0 156.7 147.8 173.2 183.8 189.3 187.2 164.3 157.6

DPO

 - 70.9 117.5 176.8 157.2 130.3 119.6 137.7 96.8 83.0 242.9

Operating Cycle

 - 333.7 676.3 245.1 241.6 260.1 279.6 284.9 187.2 164.3 157.6

Cash Conversion Cycle

 - 262.8 558.8 68.3 84.4 129.8 160.0 147.2 90.4 81.4 -85.3

All numbers in JPY currency

Quarterly Financial Ratios Takeda Pharmaceutical Company Limited

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

EBITDA per Share

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROE %

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROA %

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

ROCE %

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Current Ratio

 - - - 1.8 - - - 1.7 - - - 1.6 - - - 1.6 - - - 2.0 - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in JPY currency